Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Gelman

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Molecular and Cellular Biology|August 19, 2015
Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive DisorderWooJin Kim, Erin Zekas, Robert Lodge, et al.
Journal of Clinical and Experimental Neuropsychology|March 11, 2011
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological changeLucette A Cysique, Donald Franklin, Ian Abramson, et al.
AIDS (London, England)|February 1, 2019
Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effectsIgnacio Pérez-Valero, Ronald Ellis, Robert Heaton, et al.
AIDS and Behavior|June 23, 2012
Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIVDoyle E Patton, Steven Paul Woods, Donald Franklin, et al.
Pain|February 7, 2015
Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapyJemily Malvar, Florin Vaida, Chelsea Fitzsimons Sanders, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2013
Etravirine in CSF is highly protein boundAnh Nguyen, Steven Rossi, David Croteau, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1David Croteau, Scott Letendre, Brookie M Best, et al.
AIDS (London, England)|March 15, 2019
Effects of comorbidity burden and age on brain integrity in HIVRowan Saloner, Robert K Heaton, Laura M Campbell, et al.
Journal of Clinical and Experimental Neuropsychology|January 14, 2011
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individualsKenny Lin, Michael J Taylor, Robert Heaton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 5, 2011
Neurocognitive impact of substance use in HIV infectionDesiree A Byrd, Robert P Fellows, Susan Morgello, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Biology|August 19, 2015
Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive DisorderWooJin Kim, Erin Zekas, Robert Lodge, et al.
Journal of Clinical and Experimental Neuropsychology|March 11, 2011
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological changeLucette A Cysique, Donald Franklin, Ian Abramson, et al.
AIDS (London, England)|February 1, 2019
Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effectsIgnacio Pérez-Valero, Ronald Ellis, Robert Heaton, et al.
AIDS and Behavior|June 23, 2012
Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIVDoyle E Patton, Steven Paul Woods, Donald Franklin, et al.
Pain|February 7, 2015
Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapyJemily Malvar, Florin Vaida, Chelsea Fitzsimons Sanders, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2013
Etravirine in CSF is highly protein boundAnh Nguyen, Steven Rossi, David Croteau, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1David Croteau, Scott Letendre, Brookie M Best, et al.
AIDS (London, England)|March 15, 2019
Effects of comorbidity burden and age on brain integrity in HIVRowan Saloner, Robert K Heaton, Laura M Campbell, et al.
Journal of Clinical and Experimental Neuropsychology|January 14, 2011
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individualsKenny Lin, Michael J Taylor, Robert Heaton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 5, 2011
Neurocognitive impact of substance use in HIV infectionDesiree A Byrd, Robert P Fellows, Susan Morgello, et al.
Pageof 3